WXSH-0057

N/A

Report date: 2024/01/03 16:22:16
NME

Base Information

Drug NameWXSH-0057
Drug Alias NameWXSH0057WXSH-0057LC004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBTK C481S inhibitors
TargetsBTK C481S
Therapy Area/IndicationsHematologic NeoplasmsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Longchuan Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Longchuan Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A